Status:
COMPLETED
Study of Tocilizumab (RoActemre) Administered Subcutaneously in Participants With Rheumatoid Arthritis in Everyday Clinical Practice
Lead Sponsor:
Hoffmann-La Roche
Collaborating Sponsors:
Chugai Pharma Europe Ltd.
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
ARATA is a prospective, non-interventional, multicenter, observational study in Germany to evaluate the long-term effectiveness and tolerability of subcutaneously administered tocilizumab in participa...
Eligibility Criteria
Inclusion
- Participants who have not yet been treated with tocilizumab
- Participants who have received the first injection with tocilizumab maximum 1 month before inclusion in the study and the necessary baseline data and disease characteristics are present
Exclusion
- Participants who at the time of the study inclusion are participating in a different interventional study on rheumatoid arthritis
Key Trial Info
Start Date :
May 20 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 23 2020
Estimated Enrollment :
1454 Patients enrolled
Trial Details
Trial ID
NCT02251860
Start Date
May 20 2014
End Date
July 23 2020
Last Update
September 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CIRI - Centrum für Innovative Diagnostik und Therapie Rheumatologie/ Immunologie (GmbH)
Frankfurt, Germany, 60528